Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results
- 2 December 1998
- Vol. 16 (20) , 1933-1935
- https://doi.org/10.1016/s0264-410x(98)00126-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccinationVaccine, 1996
- Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccineVaccine, 1995
- Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a boosterEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Duration and Efficacy of Immune Response to Hepatitis B Vaccine in High-Risk Chinese AdolescentsClinical Infectious Diseases, 1993
- Recombinant DNA Hepatitis B Vaccination in Teenagers: Effect of a Booster at 51/2 YearsThe Journal of Infectious Diseases, 1992
- Immunization against hepatitis B-what can we expect?: Results of a survey of antibody response to immunization in persons ‘at risk’ of occupational exposure to hepatitis BEpidemiology and Infection, 1990
- Vaccination against Hepatitis B: Comparison of Three Different Vaccination SchedulesThe Journal of Infectious Diseases, 1989
- Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo populationJAMA, 1989
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?The Lancet, 1984